Substance Use Disorders and Pain Management: MATE Act Training _ _______________________________
F inal E xam
SUBSTANCE USE DISORDERS AND PAIN MANAGEMENT: MATE ACT TRAINING
Select the best answer for each question and mark your answers on the Final Examination Answer Sheet found on page 67, or complete your test online at BOOK.CME.EDU. A passing grade of at least 70% must be achieved in order to receive credit for this course.
41. Which of the following is a risk factor for the development of a substance use disorder? A) Genetic predisposition
45. Which of the following is a common side effect associated with naltrexone? A) Dizziness B) Weight gain C) Difficulty breathing D) Decreased interest in sex
B) Adverse childhood experiences C) Children with conduct problems D) All of the above
42. All of the following are diagnostic criteria for substance use disorders, EXCEPT: A) Tolerance B) Withdrawal C) Recreational use D) Persistent desire or unsuccessful efforts to cut down or control use 43. Which of the following statements regarding contingency management interventions is TRUE? A) There is little evidence that substance use is sensitive to the application of contingencies. B) Contrived contingencies are less likely to result in relapse to drug use following removal of the reinforcer. C) Naturalistic contingencies are less likely to maintain the initial gains made by the patient and to facilitate the sustained change of behavior over time. D) The goal is to increase the opportunity cost of substance use by arranging an environment where drug use results in the forfeiture of a predetermined item or privilege. 44. Which of the following is NOT a primary area addressed by coping and social skill training (CSST)? A) Solitude training B) Cognitive and affective regulation C) Coping skills to manage stressful life events
46. For the treatment of alcohol use disorder, the oral dosage of acamprosate is A) one 333-mg delayed-release tablet twice daily. B) three 50-mg immediate-release tablets twice daily. C) two 333-mg delayed-release tablets three times daily. D) two 100-mg delayed-release tablets three times daily. 47. Which of the following drugs is considered the criterion standard in reversing respiratory depression and coma in acute opioid overdose? A) LAAM B) Naloxone C) Methadone D) Buprenorphine
48. The opioid agonist most frequently used in opioid withdrawal is
A) LAAM. B) naloxone. C) methadone. D) buprenorphine.
49. Studies have shown one-year treatment retention rates in methadone programs of
A) 25%. B) 50%. C) 80%. D) 100%.
50. Methadone maintenance is initiated at a dose of A) 5–10 mg. B) 25–30 mg.
D) Coping skills when substances or substance-related cues are encountered
C) 60–120 mg. D) 120–240 mg.
Test questions continue on next page
64
MDNJ1525
Powered by FlippingBook